Searched for: subject%3A%22Blood%255C%2BCoagulation%22
(1 - 20 of 39)

Pages

Cardiovascular risk markers during treatment with estradiol and trimegestone or dydrogesterone
Cardiovascular risk markers during treatment with estradiol and trimegestone or dydrogesterone
Comparison of a transdermal contraceptive patch vs. oral contraceptives on hemostasis variables
Comparison of a transdermal contraceptive patch vs. oral contraceptives on hemostasis variables
Fluid loss does not explain coagulation activation during air travel
Fluid loss does not explain coagulation activation during air travel
A guide to murine coagulation factor structure, function, assays, and genetic alterations
A guide to murine coagulation factor structure, function, assays, and genetic alterations
Comparative effects of a contraceptive vaginal ring delivering a nonandrogenic progestin and continuous ethinyl estradiol and a combined oral contraceptive containing levonorgestrel on hemostasis variables
Comparative effects of a contraceptive vaginal ring delivering a nonandrogenic progestin and continuous ethinyl estradiol and a combined oral contraceptive containing levonorgestrel on hemostasis variables
A model for the harmonisation of test results of different quantitative D-dimer methods
A model for the harmonisation of test results of different quantitative D-dimer methods
Fibrinolytic efficacy of amediplase, tenecteplase and scu-PA in different external plasma clot lysis models
Fibrinolytic efficacy of amediplase, tenecteplase and scu-PA in different external plasma clot lysis models
The effects of 12 weeks of HMR 3339, a novel selective estrogen receptor modulator, on markers of coagulation and fibrinolysis: A randomized, placebo-controlled, double-blind, dose-ranging study in healthy postmenopausal women
The effects of 12 weeks of HMR 3339, a novel selective estrogen receptor modulator, on markers of coagulation and fibrinolysis: A randomized, placebo-controlled, double-blind, dose-ranging study in healthy postmenopausal women
Hepatic low-density lipoprotein receptor-related protein deficiency in mice increases atherosclerosis independent of plasma cholesterol
Hepatic low-density lipoprotein receptor-related protein deficiency in mice increases atherosclerosis independent of plasma cholesterol
Clot penetration and fibrin binding of amediplase, a chimeric plasminogen activator (K2tu-PA)
Clot penetration and fibrin binding of amediplase, a chimeric plasminogen activator (K2tu-PA)
Variable hypocoagulant effect of fish oil intake in humans: Modulation of fibrinogen level and thrombin generation
Variable hypocoagulant effect of fish oil intake in humans: Modulation of fibrinogen level and thrombin generation
Analysis of coagulation cascade and endothelial cell activation during inhibition of vascular endothelial growth factor/vascular endothelial growth factor receptor pathway in cancer patients
Analysis of coagulation cascade and endothelial cell activation during inhibition of vascular endothelial growth factor/vascular endothelial growth factor receptor pathway in cancer patients
13-Week oral toxicity study with isomaltulose (Palatinose®) in rats
13-Week oral toxicity study with isomaltulose (Palatinose®) in rats
The effect of alcohol ingestion on the exercise-induced changes in fibrin and fibrinogen degradation products in man
The effect of alcohol ingestion on the exercise-induced changes in fibrin and fibrinogen degradation products in man
Acceleration of fibrinolysis by high-frequency ultrasound: The contribution of acoustic streaming and temperature rise
Acceleration of fibrinolysis by high-frequency ultrasound: The contribution of acoustic streaming and temperature rise
Importance of levonorgestrel dose in oral contraceptives for effects on coagulation
Importance of levonorgestrel dose in oral contraceptives for effects on coagulation
13-week oral toxicity study with stanol esters in rats
13-week oral toxicity study with stanol esters in rats
Both raloxifene and estrogen reduce major cardiovascular risk factors in healthy postmenopausal women: A 2-year, placebo-controlled study
Both raloxifene and estrogen reduce major cardiovascular risk factors in healthy postmenopausal women: A 2-year, placebo-controlled study
Hypocoagulant and lipid-lowering effects of dietary n-3 polyunsaturated fatty acids with unchanged platelet activation in rats
Hypocoagulant and lipid-lowering effects of dietary n-3 polyunsaturated fatty acids with unchanged platelet activation in rats
Effect of oral contraceptives on haemostasis variables
Effect of oral contraceptives on haemostasis variables
Searched for: subject%3A%22Blood%255C%2BCoagulation%22
(1 - 20 of 39)

Pages